Multiple independent labs offer redundancy
These include: Neurological symptoms : tingling or numbness in hands and feet (peripheral neuropathy), difficulty walking or balance problems, memory difficulties, or mood changes including depression Haematological signs : persistent fatigue, weakness, pale or jaundiced skin, or shortness of breath Glossitis : a sore, red, smooth tongue Cognitive symptoms : difficulty concentrating, confusion, or "brain fog" Seek urgent medical attention if you experience rapidly worsening neurological symptoms, significant difficulty walking, severe paraesthesia, or marked cognitive decline, as these may require immediate assessment
But I am saying that with low numbers like these, it makes it easy to create a connection where there is none which can make evaluating this data particularly difficult
If you review the potential side effects and drug interactions, you can understand why the risk of the medication combination could be too high for some patients
MOA (Quick Clinical Overview): Ozempic is a GLP-1 receptor agonist that: Enhances glucose-dependent insulin secretion Suppresses inappropriate glucagon release Delays gastric emptying Reduces appetite and caloric intake This results in improved glycemic control, weight reduction, and cardiovascular risk benefit in eligible T2DM patients